Applicant profile

Johnson & Johnson Surgical Vision, Inc

Johnson & Johnson Medtech
Hong Kong MDACS·United States·12 registered devices·Oct 19, 2018Sep 02, 2024
12
Total devices
3
Risk classes
2018
First registration
2024
Most recent
Applicant overview
Bilingual manufacturer details sourced from Hong Kong MDACS
Applicant (EN)
Johnson & Johnson Surgical Vision, Inc
Applicant (ZH)
Johnson & Johnson Medtech
Country
United States
美国
Address
31 Technology Drive, Suite 200, Irvine, CA 92618, United States of America
31 Technology Drive, Suite 200, Irvine, CA 92618, 美国
Timeline
First registration
Oct 19, 2018
Most recent
Sep 02, 2024
Risk class breakdown
II
1
III
10
IV
1
Recent MDACS registrations
Latest 15 devices linked to this applicant
DeviceRisk classAuthorised repRegistered
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
IIIAMO Asia LimitedSep 02, 2024
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
IIIAMO Asia LimitedAug 08, 2024
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
IIIAMO Asia LimitedJun 24, 2024
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
IIIAMO Asia LimitedApr 18, 2024
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
IIIAMO Asia LimitedMar 21, 2024
Topical Solution/Creams, Eye Lubrication
外用溶液/乳膏,眼部润滑
IIIBausch & Lomb (Hong Kong) Ltd.Mar 07, 2024
Topical Solution/Creams, Eye Lubrication
外用溶液/乳膏,眼部润滑
IIIBausch & Lomb (Hong Kong) Ltd.Dec 22, 2023
Topical Solution/Creams, Eye Lubrication
外用溶液/乳膏,眼部润滑
IIIBausch & Lomb (Hong Kong) Ltd.Dec 22, 2023
Aqueous/Vitreous Humor Replacement Media
房水/玻璃体液替代培养基
IVAMO Asia LimitedJul 26, 2023
Intraocular Lens Inserters
人工晶状体插入器
IIAMO Asia LimitedJul 26, 2023
Lenses, Intraocular, Posterior Chamber
晶状体,眼内,后房
IIIAMO Asia LimitedJul 26, 2023
Cataract Extraction Phacoemulsification/Vitrectomy Systems
白内障摘除超声乳化术/玻璃体切除术系统
IIIAMO Asia LimitedOct 19, 2018
About this profile

Johnson & Johnson Surgical Vision, Inc is associated with 12 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.